Teleflex (TFX) Competitors

$135.32 +2.58 (+1.94%)

Closing price 03:59 PM Eastern

Extended Trading

$135.18 -0.13 (-0.10%)

As of 06:33 PM Eastern

TFX vs. STE, GMED, PODD, MASI, and BAX

Should you buy Teleflex stock or one of its competitors? MarketBeat compares Teleflex with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Teleflex include STERIS (STE), Globus Medical (GMED), Insulet (PODD), Masimo (MASI), and Baxter International (BAX). These companies are all part of the "health care equipment" industry.

How does Teleflex compare to STERIS?

Teleflex (NYSE:TFX) and STERIS (NYSE:STE) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Teleflex has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, STERIS has a beta of 0.95, indicating that its share price is 5% less volatile than the broader market.

STERIS has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	3.01	-$905.64M	-$22.80	N/A
STERIS	$5.94B	3.56	$782.30M	$7.93	27.18

95.6% of Teleflex shares are held by institutional investors. Comparatively, 94.7% of STERIS shares are held by institutional investors. 0.7% of Teleflex shares are held by company insiders. Comparatively, 1.1% of STERIS shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

STERIS has a net margin of 13.18% compared to Teleflex's net margin of -35.88%. STERIS's return on equity of 14.15% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
STERIS	13.18%	14.15%	9.52%

Teleflex presently has a consensus target price of $144.00, suggesting a potential upside of 6.41%. STERIS has a consensus target price of $275.67, suggesting a potential upside of 27.91%. Given STERIS's stronger consensus rating and higher possible upside, analysts plainly believe STERIS is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.22
STERIS	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Teleflex had 7 more articles in the media than STERIS. MarketBeat recorded 13 mentions for Teleflex and 6 mentions for STERIS. Teleflex's average media sentiment score of 0.44 beat STERIS's score of 0.41 indicating that Teleflex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
STERIS	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. STERIS pays an annual dividend of $2.52 per share and has a dividend yield of 1.2%. Teleflex pays out -6.0% of its earnings in the form of a dividend. STERIS pays out 31.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has increased its dividend for 20 consecutive years. STERIS is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

STERIS beats Teleflex on 14 of the 19 factors compared between the two stocks.

How does Teleflex compare to Globus Medical?

Globus Medical (NYSE:GMED) and Teleflex (NYSE:TFX) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Globus Medical has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Teleflex has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

Globus Medical currently has a consensus target price of $106.36, indicating a potential upside of 26.55%. Teleflex has a consensus target price of $144.00, indicating a potential upside of 6.41%. Given Globus Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Globus Medical is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.81
Teleflex	1 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.22

In the previous week, Teleflex had 6 more articles in the media than Globus Medical. MarketBeat recorded 13 mentions for Teleflex and 7 mentions for Globus Medical. Globus Medical's average media sentiment score of 0.49 beat Teleflex's score of 0.44 indicating that Globus Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Teleflex	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Globus Medical has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94B	3.88	$537.87M	$4.30	19.55
Teleflex	$1.99B	3.01	-$905.64M	-$22.80	N/A

95.2% of Globus Medical shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 18.4% of Globus Medical shares are owned by insiders. Comparatively, 0.7% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Globus Medical has a net margin of 18.92% compared to Teleflex's net margin of -35.88%. Globus Medical's return on equity of 13.46% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	18.92%	13.46%	11.65%
Teleflex	-35.88%	13.29%	6.55%

Summary

Globus Medical beats Teleflex on 15 of the 17 factors compared between the two stocks.

How does Teleflex compare to Insulet?

Insulet (NASDAQ:PODD) and Teleflex (NYSE:TFX) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, Teleflex had 2 more articles in the media than Insulet. MarketBeat recorded 13 mentions for Teleflex and 11 mentions for Insulet. Teleflex's average media sentiment score of 0.44 beat Insulet's score of 0.41 indicating that Teleflex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	2 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teleflex	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Insulet presently has a consensus price target of $254.96, indicating a potential upside of 62.82%. Teleflex has a consensus price target of $144.00, indicating a potential upside of 6.41%. Given Insulet's stronger consensus rating and higher possible upside, equities research analysts clearly believe Insulet is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.74
Teleflex	1 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.22

95.6% of Teleflex shares are held by institutional investors. 0.4% of Insulet shares are held by insiders. Comparatively, 0.7% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Insulet has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

Insulet has a net margin of 10.44% compared to Teleflex's net margin of -35.88%. Insulet's return on equity of 26.87% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	10.44%	26.87%	12.01%
Teleflex	-35.88%	13.29%	6.55%

Insulet has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.90B	3.74	$247.10M	$4.30	36.42
Teleflex	$1.99B	3.01	-$905.64M	-$22.80	N/A

Summary

Insulet beats Teleflex on 12 of the 16 factors compared between the two stocks.

How does Teleflex compare to Masimo?

Teleflex (NYSE:TFX) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

In the previous week, Teleflex had 10 more articles in the media than Masimo. MarketBeat recorded 13 mentions for Teleflex and 3 mentions for Masimo. Teleflex's average media sentiment score of 0.44 beat Masimo's score of 0.04 indicating that Teleflex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	4 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Masimo	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Masimo has lower revenue, but higher earnings than Teleflex. Masimo is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	3.01	-$905.64M	-$22.80	N/A
Masimo	$1.53B	6.13	-$151.50M	-$10.54	N/A

Teleflex presently has a consensus target price of $144.00, indicating a potential upside of 6.41%. Masimo has a consensus target price of $180.40, indicating a potential upside of 0.90%. Given Teleflex's stronger consensus rating and higher probable upside, analysts clearly believe Teleflex is more favorable than Masimo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.22
Masimo	0 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Masimo has a net margin of 4.90% compared to Teleflex's net margin of -35.88%. Masimo's return on equity of 31.33% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
Masimo	4.90%	31.33%	13.93%

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 9.7% of Masimo shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Teleflex has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market. Comparatively, Masimo has a beta of 1.13, meaning that its share price is 13% more volatile than the broader market.

Summary

Teleflex and Masimo tied by winning 8 of the 16 factors compared between the two stocks.

How does Teleflex compare to Baxter International?

Teleflex (NYSE:TFX) and Baxter International (NYSE:BAX) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Teleflex pays out -6.0% of its earnings in the form of a dividend. Baxter International pays out -1.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

Teleflex has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	3.01	-$905.64M	-$22.80	N/A
Baxter International	$11.24B	0.86	-$957M	-$2.13	N/A

Baxter International has a net margin of -9.70% compared to Teleflex's net margin of -35.88%. Baxter International's return on equity of 16.15% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
Baxter International	-9.70%	16.15%	5.24%

Teleflex presently has a consensus target price of $144.00, indicating a potential upside of 6.41%. Baxter International has a consensus target price of $19.91, indicating a potential upside of 5.90%. Given Teleflex's stronger consensus rating and higher possible upside, equities analysts plainly believe Teleflex is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.22
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

95.6% of Teleflex shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 0.7% of Teleflex shares are held by company insiders. Comparatively, 0.2% of Baxter International shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Teleflex had 13 more articles in the media than Baxter International. MarketBeat recorded 13 mentions for Teleflex and 0 mentions for Baxter International. Teleflex's average media sentiment score of 0.44 beat Baxter International's score of -0.34 indicating that Teleflex is being referred to more favorably in the media.

Company	Overall Sentiment
Teleflex	Neutral
Baxter International	Neutral

Teleflex has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

Summary

Teleflex beats Baxter International on 14 of the 18 factors compared between the two stocks.

Get Teleflex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TFX vs. The Competition

Export

Metric	Teleflex	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$5.88B	$7.03B	$6.30B	$22.71B
Dividend Yield	1.02%	1.70%	2.80%	4.13%
P/E Ratio	-5.94	50.53	21.04	30.07
Price / Sales	3.01	73.12	529.93	17.16
Price / Cash	11.86	24.40	43.18	24.44
Price / Book	1.94	6.42	9.91	4.68
Net Income	-$905.64M	$158.81M	$3.55B	$1.07B
7 Day Performance	4.16%	1.76%	-0.30%	-0.04%
1 Month Performance	2.51%	-3.62%	-2.34%	-1.12%
1 Year Performance	6.82%	-1.60%	30.89%	22.78%

Teleflex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TFX Teleflex	4.4743 of 5 stars	$135.32 +1.9%	$144.00 +6.4%	+3.8%	$5.88B	$1.99B	N/A	15,500	Dividend Announcement
STE STERIS	4.4566 of 5 stars	$211.80 -1.9%	$275.67 +30.2%	-15.0%	$20.80B	$5.94B	26.71	17,787
GMED Globus Medical	4.802 of 5 stars	$76.52 -0.9%	$106.36 +39.0%	+30.7%	$10.40B	$3.10B	17.79	6,000
PODD Insulet	4.4545 of 5 stars	$147.46 -0.8%	$257.09 +74.3%	-52.6%	$10.21B	$2.71B	34.29	5,400	Analyst Forecast
MASI Masimo	1.2493 of 5 stars	$178.47 +0.1%	$180.40 +1.1%	+15.3%	$9.35B	$1.53B	N/A	2,200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TFX) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Teleflex (TFX) Competitors